» Articles » PMID: 21781350

Mn Bioavailability by Polarized Caco-2 Cells: Comparison Between Mn Gluconate and Mn Oxyprolinate

Overview
Journal Nutr J
Publisher Biomed Central
Date 2011 Jul 26
PMID 21781350
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Micronutrient inadequate intake is responsible of pathological deficiencies and there is a need of assessing the effectiveness of metal supplementation, frequently proposed to rebalance poor diets. Manganese (Mn) is present in many enzymatic intracellular systems crucial for the regulation of cell metabolism, and is contained in commercially available metal supplements.

Methods: We compared the effects of two different commercial Mn forms, gluconate (MnGluc) and oxyprolinate (MnOxP). For this purpose we used the polarized Caco-2 cells cultured on transwell filters, an established in vitro model of intestinal epithelium. Since micronutrient deficiency may accelerate mitochondrial efficiency, the mitochondrial response of these cells, in the presence of MnGluc and MnOxP, by microscopy methods and by ATP luminescence assay was used.

Results: In the presence of both MnOxP and MnGluc a sustained mitochondrial activity was shown by mitoTraker labeling (indicative of mitochondrial respiration), but ATP intracellular content remained comparable to untreated cells only in the presence of MnOxP. In addition MnOxP transiently up-regulated the antioxidant enzyme Mn superoxide dismutase more efficiently than MnGluc. Both metal treatments preserved NADH and βNADPH diaphorase oxidative activity, avoided mitochondrial dysfunction, as assessed by the absence of a sustained phosphoERK activation, and were able to maintain cell viability.

Conclusions: Collectively, our data indicate that MnOxP and MnGluc, and primarily the former, produce a moderate and safe modification of Caco-2 cell metabolism, by activating positive enzymatic mechanisms, thus could contribute to long-term maintenance of cell homeostasis.

Citing Articles

Bioavailability Assessment of an Iron Formulation Using Differentiated Human Intestinal Caco-2 Cells.

Fanzaga M, Bollati C, Ranaldi G, Sucato S, Fustinoni S, Roda G Foods. 2023; 12(16).

PMID: 37628015 PMC: 10453055. DOI: 10.3390/foods12163016.


Mitochondrial Energetics and Ca2-Activated ATPase in Obstructive Hypertrophic Cardiomyopathy.

Lombardi M, Lazzeroni D, Pisano A, Girolami F, Alfieri O, La Canna G J Clin Med. 2020; 9(6).

PMID: 32527005 PMC: 7356244. DOI: 10.3390/jcm9061799.

References
1.
Prasad A . Zinc: mechanisms of host defense. J Nutr. 2007; 137(5):1345-9. DOI: 10.1093/jn/137.5.1345. View

2.
Wallace K . Mitochondrial off targets of drug therapy. Trends Pharmacol Sci. 2008; 29(7):361-6. DOI: 10.1016/j.tips.2008.04.001. View

3.
Leblondel G, Allain P . Manganese transport by Caco-2 cells. Biol Trace Elem Res. 1999; 67(1):13-28. DOI: 10.1007/BF02784271. View

4.
DAVIS C, Greger J . Longitudinal changes of manganese-dependent superoxide dismutase and other indexes of manganese and iron status in women. Am J Clin Nutr. 1992; 55(3):747-52. DOI: 10.1093/ajcn/55.3.747. View

5.
Siepmann M, Spank S, Kluge A, Schappach A, Kirch W . The pharmacokinetics of zinc from zinc gluconate: a comparison with zinc oxide in healthy men. Int J Clin Pharmacol Ther. 2005; 43(12):562-5. DOI: 10.5414/cpp43562. View